Horizon Alert
Summary of the vulnerability and why it matters
A critical vulnerability has been identified in IBM Maximo Application Suite that could allow unauthorized remote access to the system by bypassing authentication. This issue affects specific versions of the software, and its exposure as an external threat warrants attention.
- Unauthenticated remote access bypassing security.
- Critical vulnerability in asset management software.
- Confirm relevance and assess potential exposure.
Attack Path
How an attacker could exploit the issue
An attacker could exploit this vulnerability by sending specially crafted requests over the network to an exposed IBM Maximo Application Suite instance. Successful exploitation could allow the attacker to bypass authentication and gain unauthorized access, potentially leading to sensitive data exposure, modification, or system disruption.
- No authentication is required.
- Exploited via network requests.
- Enables unauthorized system access.
Live Threat
Current exploitation, exposure, and threat context
IBM Maximo Application Suite, when accessible remotely, could allow an unauthenticated attacker to bypass normal login procedures. This could potentially grant them unauthorized access to the application's functionalities and data.
- Unauthorized access to application features.
- Bypassing authentication controls remotely.
- Exposure of application data and functions.
Operational Fix
Recommended remediation, mitigation, and detection steps
IBM Maximo Application Suite, an enterprise asset management platform often deployed for remote access, may be vulnerable to a critical authentication bypass. Owners of this application, potentially within infrastructure, platform, or security teams, must first identify all instances of the affected product, confirm their exposure and business criticality, and then assign an accountable owner to plan remediation.
- Application and platform teams own remediation.
- Verify all Maximo Application Suite instances.
- Plan coordinated updates and testing.